|
1
|
Bijlsma JW, Welsing PM, Woodworth TG,
Middelink LM, Pethö-Schramm A, Bernasconi C, Borm ME, Wortel CH,
Ter Borg EJ, Jahangier ZN, et al: Early rheumatoid arthritis
treated with tocilizumab, methotrexate, or their combination
(U-Act-Early): A multicentre, randomised, double-blind,
double-dummy, strategy trial. Lancet. 388:343–355. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sellam J, Marion-Thore S, Dumont F,
Jacques S, Garchon HJ, Rouanet S, Taoufik Y, Hendel-Chavez H,
Sibilia J, Tebib J, et al: Use of whole-blood transcriptomic
profiling to highlight several pathophysiologic pathways associated
with response to rituximab in patients with rheumatoid arthritis:
Data from a randomized, controlled, open-label trial. Arthritis
Rheumatol. 66:2015–2025. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tanaka Y, Kawai S, Takeuchi T, Yamamoto K
and Miyasaka N: Prevention of joint destruction by tacrolimus in
patients with early rheumatoid arthritis: A post hoc analysis of a
double-blind, randomized, placebo-controlled study. Mod Rheumatol.
23:1045–1052. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li R, Zhao JX, Su Y, He J, Chen LN, Gu F,
Zhao C, Deng XR, Zhou W, Hao YJ, et al: High remission and low
relapse with prolonged intensive DMARD therapy in rheumatoid
arthritis (PRINT): A multicenter randomized clinical trial.
Medicine (Baltimore). 95:e39682016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jia Q, Cheng W, Yue Y, Hu Y, Zhang J, Pan
X, Xu Z and Zhang P: Cucurbitacin E inhibits TNF-α-induced
inflammatory cytokine production in human synoviocyte MH7A cells
via suppression of PI3K/Akt/NF-κB pathways. Int Immunopharmacol.
29:884–890. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cho ML, Ju JH, Kim KW, Moon YM, Lee SY,
Min SY, Cho YG, Kim HS, Park KS, Yoon CH, et al: Cyclosporine A
inhibits IL-15-induced IL-17 production in CD4+ T cells via
down-regulation of PI3K/Akt and NF-kappaB. Immunol Lett. 108:88–96.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lv Q, Zhu XY, Xia YF, Dai Y and Wei ZF:
Tetrandrine inhibits migration and invasion of rheumatoid arthritis
fibroblast-like synoviocytes through down-regulating the
expressions of Rac1, Cdc42, and RhoA GTPases and activation of the
PI3K/Akt and JNK signaling pathways. Chin J Nat Med. 13:831–841.
2015.PubMed/NCBI
|
|
8
|
Kim TH, Choi SJ, Lee YH, Song GG and Ji
JD: Combined therapeutic application of mTOR inhibitor and vitamin
D(3) for inflammatory bone destruction of rheumatoid arthritis. Med
Hypotheses. 79:757–760. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang L, Yi Y, Chen J, Sun Y, Guo Q, Zheng
Z and Song S: Gambogic acid inhibits Hsp90 and deregulates
TNF-α/NF-κB in HeLa cells. Biochem Biophys Res Commun. 403:282–287.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Palempalli UD, Gandhi U, Kalantari P,
Vunta H, Arner RJ, Narayan V, Ravindran A and Prabhu KS: Gambogic
acid covalently modifies IkappaB kinase-beta subunit to mediate
suppression of lipopolysaccharide-induced activation of NF-kappaB
in macrophages. Biochem J. 419:401–409. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang Q, Lu M, Zhou H, Chen D and Liu L:
Gambogic acid inhibits the growth of ovarian cancer tumors by
regulating p65 activity. Oncol Lett. 13:384–388. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Geng J, Xiao S, Zheng Z, Song S and Zhang
L: Gambogic acid protects from endotoxin shock by suppressing
pro-inflammatory factors in vivo and in vitro. Inflamm Res.
62:165–172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma J, Ma Y, Liu X, Chen S, Liu C, Qin A
and Fan S: Gambogic acid inhibits osteoclast formation and
ovariectomy-induced osteoporosis by suppressing the JNK, p38 and
Akt signalling pathways. Biochem J. 469:399–408. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ito H, Noda K, Yoshida K, Otani K, Yoshiga
M, Oto Y, Saito S and Kurosaka D: Prokineticin 2 antagonist, PKRA7
suppresses arthritis in mice with collagen-induced arthritis. BMC
Musculoskelet Disord. 17:3872016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wen J, Pei H, Wang X, Xie C, Li S, Huang
L, Qiu N, Wang W, Cheng X and Chen L: Gambogic acid exhibits
anti-psoriatic efficacy through inhibition of angiogenesis and
inflammation. J Dermatol Sci. 74:242–250. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lal P, Su Z, Holweg CT, Silverman GJ,
Schwartzman S, Kelman A, Read S, Spaniolo G, Monroe JG, Behrens TW
and Townsend MJ: Inflammation and autoantibody markers identify
rheumatoid arthritis patients with enhanced clinical benefit
following rituximab treatment. Arthritis Rheum. 63:3681–3691. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nair SC, Welsing PM, Jacobs JW, van Laar
JM, Rensen WH, Ardine de Wit G, Bijlsma JW and Lafeber FP: Economic
evaluation of a tight-control treatment strategy using an imaging
device (handscan) for monitoring joint inflammation in early
rheumatoid arthritis. Clin Exp Rheumatol. 33:831–838.
2015.PubMed/NCBI
|
|
18
|
Kullich WC, Mur E, Aglas F, Niksic F and
Czerwenka C: Inhibitory effects of leflunomide therapy on the
activity of matrixmetalloproteinase-9 and the release of cartilage
oligomeric matrix protein in patients with rheumatoid arthritis.
Clin Exp Rheumatol. 24:155–160. 2006.PubMed/NCBI
|
|
19
|
Min HK, Kim SM, Baek SY, Woo JW, Park JS,
Cho ML, Lee J, Kwok SK, Kim SW and Park SH: Anthocyanin extracted
from black soybean seed coats prevents autoimmune arthritis by
suppressing the development of Th17 cells and synthesis of
proinflammatory cytokines by such cells, via inhibition of NF-κB.
PLoS One. 10:e01382012015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu XZ, Fan J, Qi K, Liu SP, Xu WD, Gao Y,
Gu XD, Li J, Bai CG, Shi YQ, et al: Dishevelled2 promotes apoptosis
and inhibits inflammatory cytokine secretion in rheumatoid
arthritis fibroblast-like synoviocytes through crosstalk with the
NF-κB pathway. Oncotarget. 8:12649–12663. 2017.PubMed/NCBI
|
|
21
|
Li Y, Wang LM, Xu JZ, Tian K, Gu CX and Li
ZF: Gastrodia elata attenuates inflammatory response by inhibiting
the NF-κB pathway in rheumatoid arthritis fibroblast-like
synoviocytes. Biomed Pharmacother. 85:177–181. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qi Q, Gu H, Yang Y, Lu N, Zhao J, Liu W,
Ling H, You QD, Wang X and Guo Q: Involvement of matrix
metalloproteinase 2 and 9 in gambogic acid induced suppression of
MDA-MB-435 human breast carcinoma cell lung metastasis. J Mol Med
(Berl). 86:1367–1377. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li CH, Xu LL, Zhao JX, Sun L, Yao ZQ, Deng
XL, Liu R, Yang L, Xing R and Liu XY: CXCL16 upregulates RANKL
expression in rheumatoid arthritis synovial fibroblasts through the
JAK2/STAT3 and p38/MAPK signaling pathway. Inflamm Res. 65:193–202.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim HR, Park MK, Cho ML, Kim KW, Oh HJ,
Park JS, Heo YM, Lee SH, Kim HY and Park SH: Induction of
macrophage migration inhibitory factor in ConA-stimulated
rheumatoid arthritis synovial fibroblasts through the P38 map
kinase-dependent signaling pathway. Korean J Intern Med.
25:317–326. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Han W, Xiong Y, Li Y, Fang W, Ma Y, Liu L,
Li F and Zhu X: Anti-arthritic effects of clematichinenoside (AR-6)
on PI3K/Akt signaling pathway and TNF-α associated with
collagen-induced arthritis. Pharm Biol. 51:13–22. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu Y, Pan YF, Xue YQ, Fang LK, Guo XH,
Guo X, Liu M, Mo BY, Yang MR, Liu F, et al: uPAR promotes
tumor-like biologic behaviors of fibroblast-like synoviocytes
through PI3K/Akt signaling pathway in patients with rheumatoid
arthritis. Cell Mol Immunol. Jan 16–2017.(Epub ahead of print).
|
|
27
|
Yuan FL, Xu RS, Jiang DL, He XL, Su Q, Jin
C and Li X: Leonurine hydrochloride inhibits osteoclastogenesis and
prevents osteoporosis associated with estrogen deficiency by
inhibiting the NF-κB and PI3K/Akt signaling pathways. Bone.
75:128–137. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Malemud CJ: The PI3K/Akt/PTEN/mTOR
pathway: A fruitful target for inducing cell death in rheumatoid
arthritis? Future Med Chem. 7:1137–1147. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mitra A, Raychaudhuri SK and Raychaudhuri
SP: IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR
signaling cascade. Cytokine. 60:38–42. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang F, Zhang W, Guo L, Bao W, Jin N, Liu
R, Liu P, Wang Y, Guo Q and Chen B: Gambogic acid suppresses
hypoxia-induced hypoxia-inducible factor-1α/vascular endothelial
growth factor expression via inhibiting phosphatidylinositol
3-kinase/Akt/mammalian target protein of rapamycin pathway in
multiple myeloma cells. Cancer Sci. 105:1063–1070. 2014. View Article : Google Scholar : PubMed/NCBI
|
